ReviewFrontiers in molecular biosciences2026
Microglia-neuron communication in ischemic stroke: from homeostatic signaling to pathological remodeling and therapeutic targeting.
Review in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ischemic stroke profoundly disrupts the homeostatic dialogue between microglia and neurons, converting a physiological surveillance network into a dynamic, injury-responsive, and spatially heterogeneous communication system. Under physiological conditions, neurons regulate microglia through diverse signaling pathways, while microglia support neuronal health via synaptic remodeling, inflammatory regulation, metabolic balance, and debris clearance. Following cerebral ischemia, cascades involving excitotoxicity, energy failure, ionic imbalance, damage-associated molecular patterns (DAMPs), complement activation, and cell death signals rapidly reprogram this bidirectional communication. In this Review, we propose the Microglia-Neuron Communication Continuum (MNCC) model as a conceptual framework for understanding post-stroke microglia-neuron crosstalk. The MNCC model conceptualizes these interactions as a multidimensional continuum defined by three core axes: time, communication mode, and functional outcome. Along the temporal axis, crosstalk evolves from the hyperacute and acute phases to the subacute and chronic stages. Along the communication-mode axis, interactions span direct contact-dependent mechanisms and indirect soluble signaling pathways. Along the functional-output axis, the biological consequences range from damage amplification to tissue repair and chronic maladaptation. Using this framework, we first summarize the physiological basis of bidirectional microglia-neuron signaling under homeostatic conditions. We then examine how ischemic stroke reprograms this network across distinct temporal stages and spatial niches, emphasizing that post-stroke crosstalk is a continuous, context-dependent, spatially heterogeneous, and functionally plastic process. Finally, we discuss current and emerging therapeutic strategies through the lens of the MNCC model, focusing on temporal matching, dominant communication modes, regional heterogeneity, and translational barriers. A deeper understanding of this communication continuum may facilitate the development of targeted interventions that restrain harmful signaling, preserve beneficial interactions, and ultimately improve long-term neurological recovery after ischemic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.